Philip Wehrman
PhD
Director Biology
👥Biography 个人简介
Philip Wehrman leads biology efforts for antibody drug conjugate programs focused on solid tumor targets. His work includes preclinical model development and biomarker discovery to support clinical candidate selection. He has contributed to the design of next generation ADC platforms with novel payload classes. His publications address mechanism and resistance in ADC therapy.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Philip Wehrman 的研究动态
Follow Philip Wehrman's research updates
留下邮箱，当我们发布与 Philip Wehrman（Mersana Therapeutics）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment